3178 results for «684»

Filter By

3178 results

Calcified lesions

05 Jul 2019 – From AICT-AsiaPCR 2019

Watch this LIVE demonstration from National University Heart Centre (Singapore) to discover how they managed the case of a 69 years-old male with diabetes, hypertension and hyperlipidemia suffering from a calcified triple vessel disease.

Calcified lesions

Diffuse multivessel disease

05 Jul 2019 – From AICT-AsiaPCR 2019

Diffuse multivessel disease

TAVI in a bicuspid aortic valve stenosis

05 Jul 2019 – From AICT-AsiaPCR 2019

Watch this LIVE demonstration from Clinique Pasteur (France) to learn about the case of a 81 years-old male patient with dyslipidemia referred to the hospital because of NYHA II shortness of breath related to a severe aortic stenosis. CT scan revealed a type I L-R bicuspid...

TAVI in a bicuspid aortic valve stenosis

Calcified left main lesion PCI

05 Jul 2019 – From AICT-AsiaPCR 2019

Consult this session to discover the key clinical data and angiographic reference of a patient presenting with calcified left main lesion PCI.

Calcified left main lesion PCI

A patient with LAD-diagonal bifurcation lesion

22 May 2019 – From EuroPCR 2019

A patient with LAD-diagonal

TAVI for a patient with severe aortic stenosis and a mechanical mitral prosthesis - Session with LIVE case

18 Nov 2019 – From PCR London Valves 2019

View this session with a LIVE demonstration from St Thomas' Hospital - London, United Kingdom

TAVI for a patient with

TAVI device selection for severe aortic stenosis - Session with LIVE case

18 Nov 2019 – From PCR London Valves 2019

Watch this session with a LIVE demonstration from University Hospital of Zurich (Zurich, Switzerland) to learn more about TAVI device selection and « Best practice » implantation of the Portico Valve.

TAVI device selection

TAV in TAV for an 8-year old degenerating TAVI device - Session with LIVE case

19 Nov 2019 – From PCR London Valves 2019

Watch this session with a LIVE demonstration from St Thomas' Hospital - London, United Kingdom

TAV in TAV for an 8-year

Transcatheter mitral valve-in-valve for a patient with a degenerating bioprosthesis - Session with LIVE case

18 Nov 2019 – From PCR London Valves 2019

Watch this session with a LIVE demonstration from St Thomas' Hospital - London, United Kingdom

Transcatheter mitral

TAVI in bicuspid aortic valve disease - Session with LIVE case

19 Nov 2019 – From PCR London Valves 2019

Watch this session with LIVE demonstration from Clinique Pasteur - Toulouse, France

TAVI in bicuspid aortic

Transcatheter edge-to-edge repair for secondary mitral regurgitation - Session with LIVE case

19 Nov 2019 – From PCR London Valves 2019

Watch this session with a LIVE demonstration from Clinique Pasteur - Toulouse, France

Transcatheter edge-to-edge

GulfPCR-GIM 2019 Opening Ceremony

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to discover the slides presented during GulfPCR-GIM 2019 Opening Ceremony, the leading-edge interventional course in the Middle East, and learn more about the course directors, the programme committee members, the sessions and the live centers.

GulfPCR-GIM 2019 Opening Ceremony

GulfPCR-GIM 2019 Award and Closing Ceremony

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to see the slides presented during GulfPCR-GIM 2019 Award and Closing Ceremony, which gathered 832 active participants, and discover who the best clinical case award winner was that year.

GulfPCR-GIM 2019 Award and Closing Ceremony

Management of mitral regurgitation patients undergoing TMVI screening

13 Jan 2022

This study's results emphasise the strengths and limitations of transcatheter mitral valve implantation (TMVI) as a novel and promising therapy providing predictable elimination of MR in most patients, by S. Ludwig et al.

Management of mitral regurgitation patients undergoing TMVI screening

5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)

01 Apr 2025

Yohei Ohno provides his takeaways from the results of the Evolut Low Risk trial which was presented by Michael J. Reardon during the ACC.25 in Chicago.

Yohei Ohno

Author

Yohei Ohno
5-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis (Evolut Low Risk)

PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial

18 May 2021

Transcatheter aortic valve implantation (TAVI) offers an effective, less invasive therapeutic alternative to surgical aortic valve replacement in patients with symptomatic, severe aortic stenosis. Although TAVI is demonstrated to be superior to medical therapy or surgery in patients who are at prohibitive or high risk for...

PCR STATEMENT on the 2-year clinical outcomes from the Evolut low risk trial

30 years of primary PCI – a tale of perseverance

16 May 2023

Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.

30 years of primary PCI – a tale of perseverance

Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial

05 Mar 2023

Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.

Luigi Biasco

Author

Luigi Biasco
Transcatheter versus surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut low risk Trial
Didn’t find what you were looking for?